Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma
BackgroundAs essential components of cycle growth, the cell division cycle-associated family genes (CDCAs) have crucial roles in tumor development and progression, especially in hepatocellular carcinoma (HCC). However, due to the tumor heterogeneity of HCC, little is known about the methylation vari...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.566183/full |
id |
doaj-5b786f29f02a4f4eae6da42bfb54f7a0 |
---|---|
record_format |
Article |
spelling |
doaj-5b786f29f02a4f4eae6da42bfb54f7a02021-02-16T06:06:14ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011010.3389/fonc.2020.566183566183Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular CarcinomaYongkang Wang0Yinfeng Yang1Yinfeng Yang2Honglei Gao3Ting Ouyang4Luyao Zhang5Jili Hu6Sheng Hu7Hongxing Kan8Hongxing Kan9School of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, ChinaAnhui Computer Application Research Institute of Chinese Medicine, China Academy of Chinese Medical Sciences, Hefei, ChinaSchool of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Medical Informatics Engineering, Anhui University of Chinese Medicine, Hefei, ChinaAnhui Computer Application Research Institute of Chinese Medicine, China Academy of Chinese Medical Sciences, Hefei, ChinaBackgroundAs essential components of cycle growth, the cell division cycle-associated family genes (CDCAs) have crucial roles in tumor development and progression, especially in hepatocellular carcinoma (HCC). However, due to the tumor heterogeneity of HCC, little is known about the methylation variability of CDCAs in mediating phenotypic changes (e.g., immune infiltrates) in HCC. Presently, we aim to comprehensively explore the expression and prognosis of CDCAs methylation with regard to immune infiltrates of HCC.MethodsWe first identified the correlating differentially expressed genes (co-DEGs) among 19 different types of cancer cohorts (a total of 7,783 patients) and then constructed the weighted gene co-expressed and co-methylated networks. Applying the clustering analysis, significant modules of DEGs including CDCAs were selected and their functional bioinformatics analyses were performed. Besides, using DiseaseMeth and TIMER, the correlation between the methylation levels of CDCAs and tumor immune infiltrates was also analyzed. In final, to assess the influence of CDCAs methylation on clinical prognosis, Kaplan-Meier and Cox regression analysis were carried out.ResultA total of 473 co-DEGs are successfully identified, while seven genes of CDCAs (CDCA1–3 and CDCA5–8) have significant over-expression in HCC. Co-expressed and co-methylated networks reveal the strong positive correlations in mRNA expression and methylation levels of CDCAs. Besides, the biological enrichment analysis of CDCAs demonstrates that they are significantly related to the immune function regulation of infiltrating immune cells in HCC. Also, the methylation analysis of CDCAs depicts the strong association with the tumor immunogenicity, i.e., low-methylation of CDCA1, CDCA2, and CDCA8 dramatically reduced the immune infiltrate levels of T cells and cytotoxic lymphocytes. Additionally, CDCA1–6 and CDCA8 with low-methylation levels significantly deteriorate the overall survival of patients in HCC.ConclusionsThe co-expressed and co-methylated gene networks of CDCAs show a powerful association with immune function regulation. And the methylation levels of CDCAs suggesting the prognostic value and infiltrating immune differences could be a novel and predictive biomarker for the response of immunotherapy.https://www.frontiersin.org/articles/10.3389/fonc.2020.566183/fullhepatocellular carcinomaCDCADNA methylationimmune infiltratespredictive biomarker |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yongkang Wang Yinfeng Yang Yinfeng Yang Honglei Gao Ting Ouyang Luyao Zhang Jili Hu Sheng Hu Hongxing Kan Hongxing Kan |
spellingShingle |
Yongkang Wang Yinfeng Yang Yinfeng Yang Honglei Gao Ting Ouyang Luyao Zhang Jili Hu Sheng Hu Hongxing Kan Hongxing Kan Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma Frontiers in Oncology hepatocellular carcinoma CDCA DNA methylation immune infiltrates predictive biomarker |
author_facet |
Yongkang Wang Yinfeng Yang Yinfeng Yang Honglei Gao Ting Ouyang Luyao Zhang Jili Hu Sheng Hu Hongxing Kan Hongxing Kan |
author_sort |
Yongkang Wang |
title |
Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma |
title_short |
Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma |
title_full |
Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma |
title_fullStr |
Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma |
title_full_unstemmed |
Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma |
title_sort |
comprehensive analysis of cdcas methylation and immune infiltrates in hepatocellular carcinoma |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-02-01 |
description |
BackgroundAs essential components of cycle growth, the cell division cycle-associated family genes (CDCAs) have crucial roles in tumor development and progression, especially in hepatocellular carcinoma (HCC). However, due to the tumor heterogeneity of HCC, little is known about the methylation variability of CDCAs in mediating phenotypic changes (e.g., immune infiltrates) in HCC. Presently, we aim to comprehensively explore the expression and prognosis of CDCAs methylation with regard to immune infiltrates of HCC.MethodsWe first identified the correlating differentially expressed genes (co-DEGs) among 19 different types of cancer cohorts (a total of 7,783 patients) and then constructed the weighted gene co-expressed and co-methylated networks. Applying the clustering analysis, significant modules of DEGs including CDCAs were selected and their functional bioinformatics analyses were performed. Besides, using DiseaseMeth and TIMER, the correlation between the methylation levels of CDCAs and tumor immune infiltrates was also analyzed. In final, to assess the influence of CDCAs methylation on clinical prognosis, Kaplan-Meier and Cox regression analysis were carried out.ResultA total of 473 co-DEGs are successfully identified, while seven genes of CDCAs (CDCA1–3 and CDCA5–8) have significant over-expression in HCC. Co-expressed and co-methylated networks reveal the strong positive correlations in mRNA expression and methylation levels of CDCAs. Besides, the biological enrichment analysis of CDCAs demonstrates that they are significantly related to the immune function regulation of infiltrating immune cells in HCC. Also, the methylation analysis of CDCAs depicts the strong association with the tumor immunogenicity, i.e., low-methylation of CDCA1, CDCA2, and CDCA8 dramatically reduced the immune infiltrate levels of T cells and cytotoxic lymphocytes. Additionally, CDCA1–6 and CDCA8 with low-methylation levels significantly deteriorate the overall survival of patients in HCC.ConclusionsThe co-expressed and co-methylated gene networks of CDCAs show a powerful association with immune function regulation. And the methylation levels of CDCAs suggesting the prognostic value and infiltrating immune differences could be a novel and predictive biomarker for the response of immunotherapy. |
topic |
hepatocellular carcinoma CDCA DNA methylation immune infiltrates predictive biomarker |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2020.566183/full |
work_keys_str_mv |
AT yongkangwang comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT yinfengyang comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT yinfengyang comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT hongleigao comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT tingouyang comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT luyaozhang comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT jilihu comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT shenghu comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT hongxingkan comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma AT hongxingkan comprehensiveanalysisofcdcasmethylationandimmuneinfiltratesinhepatocellularcarcinoma |
_version_ |
1724268027197784064 |